90.9 WBUR - Boston's NPR news station
Top Stories:
PLEDGE NOW
Gene Mutation May Hold The Secret To The Next Cholesterol Drug

We hear about the genetic mutation that crushes cholesterol, and maybe heart disease, and the race to bring it to you.

Detroit Medical Center nurse Etrulia Lake checks the cholesterol level of Ken Bartell during a health screening for African American men, Saturday June 20, 2009. According to the CDC, about 1 in every 3 adults in the U.S. has high LDL (the "bad") cholesterol. (Steve Perez, The Detroit Free Press/AP)

Detroit Medical Center nurse Etrulia Lake checks the cholesterol level of Ken Bartell during a health screening for African American men, Saturday June 20, 2009. According to the CDC, about 1 in every 3 adults in the U.S. has high LDL, or “bad,” cholesterol. (Steve Perez, The Detroit Free Press/AP)

It reads like a sci-fi thriller.  One healthy, young, innocent mom – a fit aerobics instructor outside Dallas – carries a mutant gene that could save the nation from its biggest killer.  In fact, a double dose of a genetic mutation that drives the killer – bad cholesterol, LDL, with its deadly partner, heart disease – to unbelievable lows.  Levels no one thought possible.

She’s been found.  The genetics have been laid out.  And the race is now on to make the cholesterol-crushing super-drug that could one day crush America’s Number One killer – heart disease.

This hour On Point:  the mutant gene, and the race for that drug.

- Tom Ashbrook

Guests

Gina Kolata, science and medicine reporter for The New York Times, who recently wrote “Rare Mutation Ignites Race For Cholesterol Drug” She’s also the author of “Rethinking Thin: The New Science of Weight Loss and the Myths and Realities of Dieting.” (@ginakolata)

Dr. Gary Gibbons, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health.

Sean Harper, executive vice president of Research and Development at Amgen, a company that discovers, develops, manufactures and delivers innovative human therapeutics.

From Tom’s Reading List

The New York Times: Rare Mutation Ignites Race for Cholesterol Drug — “The discovery of the mutation and of the two women with their dazzlingly low LDL levels has set off one of the greatest medical chases ever. It is a fevered race among three pharmaceutical companies, Amgen, Pfizer and Sanofi, to test and win approval for a drug that mimics the effects of the mutation, drives LDL levels to new lows and prevents heart attacks. All three companies have drugs in clinical trials and report that their results, so far, are exciting.”

Nature: Gene-Based Therapeutic Approaches — “Can we take genetic “pills” for disease-related mutations? No, not yet, but our knowledge of the human genome sequence has enabled the development of other gene-based therapeutic approaches.”

Health Resources

American Heart Association: Cholesterol — “Cholesterol itself isn’t bad. We all have and need this wax-like substance in our bodies. Learn about the so-called ‘good’ and ‘bad’ cholesterol, where it comes from, and why it’s important for your health.”

CDC: Cholesterol — “Having high blood cholesterol puts you at risk for heart disease, the leading cause of death in the United States. About 1 of every 6 adult Americans has high blood cholesterol.”

FDA: Cholesterol And Statins Infographic — “Cholesterol has a bad rap. In reality, your body needs cholesterol to make hormones, vitamin D, and bile acids that help you digest food in your intestines. Cholesterol keeps you healthy. However, too much of one type (LDL or Low-Density Liproteins) or not enough of another (HDL or High-Density Lipoproteins) can put you at risk for heart disease, heart attack, or stroke.”

NIH: What Is Cholesterol? — “Your body needs some cholesterol to make hormones, vitamin D, and substances that help you digest foods. Your body makes all the cholesterol it needs. However, cholesterol also is found in some of the foods you eat.”

 

Please follow our community rules when engaging in comment discussion on this site.
ONPOINT
TODAY
Nov 24, 2014
In this photo taken Wednesday, July 30, 2014, Silicon Valley pioneer and Silent Circle co-founder Jon Callas holds up Blackphone with encryption apps displayed on it at the Computer History Museum in Mountain View, Calif.  (AP)

We’ll look at privacy, security, and the battle heating up between intelligence agencies and tech companies that are moving to encrypt your communication.

Nov 24, 2014
Homeless people stay with their belongings under the Pontchartrain Expressway overpass in New Orleans, Wednesday, Aug. 13, 2014. The city’s health department put up notices Monday giving the estimated 150 homeless people 72 hours to leave the area. (AP)

Smashing the assumptions about what it’s really like to live in poverty in America.

RECENT
SHOWS
Nov 21, 2014
Laura Ingalls Wilder, an American  writer and novelist, at age 27. Her "Little House" series is a beloved semi-autobiographical take on her childhood in the Western American plains. (South Dakota State Historical Society )

A big new look at the legacy of Laura Ingalls Wilder and the woman behind the Little House.

 
Nov 21, 2014
President Barack Obama announces executive actions on immigration during a nationally televised address from the White House in Washington, Thursday, Nov. 20, 2014.  (AP)

The president throws down the gauntlet on immigration. Bloodshed and new tensions in Israel. Keystone fails. Our weekly news roundtable goes behind the headlines.

On Point Blog
On Point Blog
Calling All Interns, Calling All Interns
Monday, Nov 24, 2014

Have you ever thought about interning with On Point Radio? Good news: your time is now!

More »
Comment
 
The Explicast, Episode Six: What Does A White House Press Correspondent Do?
Friday, Nov 21, 2014

We turn to White House Press Correspondents all the time for news, but we’ve never really wondered how they gather their information. Fortunately, our guest host Jessica Yellin had time to sit down with The Explicast to explain.

More »
Comment
 
Our Week In The Web: November 21, 2014
Friday, Nov 21, 2014

We offer a panel of hand-drawn digital sheep, and wonder how to best lead the rest of you to programs that matter.

More »
2 Comments